Indianapolis, Indiana-based Corteva, Inc. (CTVA) operates in the agriculture business and develops and supplies germplasm and traits in corn, soybean, and sunflower seed markets. Valued at a market cap of almost $41.1 billion, the company also supplies products that protect plants against weeds, insects, other pests, and diseases, as well as products that enhance crop health.
Companies worth $10 billion or more are generally described as “large-cap” stocks, and CTVA fits right into that category. The company has established itself as a leader in developing new seed and crop chemical products and serves roughly 10 million farmers and customers in 125 countries.
